Research programme: estrogen receptor-beta-selective agonists - Radius
Latest Information Update: 04 Nov 2017
Price : $50 *
At a glance
- Originator University of Illinois
- Developer Radius Health Inc.
- Mechanism of Action Selective estrogen receptor beta agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Endometriosis; Inflammation
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Endometriosis in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in USA
- 07 Mar 2008 This programme is still in active development